CIMZIA

The contents of this site are intended for US Healthcare Professionals.

Please confirm that you are a US healthcare professional. Click "Yes" to proceed or "No" to remain on this page.

Yes No
CIMZIA for Rheumatoid Arthritis CIMZIA for Crohn's Disease CIMZIA® (certolizumabpegol) a treatment option for adults with Crohn's disease and Rheumatoid Arthritis.

CIMZIA is indicated for the treatment of adults with moderate to severe rheumatoid arthritis

CIMZIA is used to lessen the signs and symptoms of moderately to severely active Crohn's disease in adults who have not been helped enough by usual treatments.

Important Safety Information
Serious infections have happened in patients taking CIMZIA, including tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some patients have died from these infections.

Please click here for additional Important Safety Information you should know about CIMZIA and discuss it with your doctor.

The CIMZIA Co-Pay Saving Card
CIMplicity, the CIMZIA treatment support program designed to help people living with rheumatoid arthritis or Crohn's disease

CIMplicity® is a comprehensive patient support program for CIMZIA® designed to help those living with rheumatoid arthritis or Crohn's disease. With CIMplicity, you can get access to patient education services, insurance support, and financial assistance. Get up to 12 months of CIMZIA with no out-of-pocket costs to you.*

*The CIMplicity programs are provided as a service of UCB, Inc., and are intended to support appropriate use of CIMZIA. Any CIMplicity program may be amended or cancelled at any time without notice. Some program and eligibility restrictions may apply. Please consult your doctor if you have any questions about your condition or treatment. Subject to eligibility. Restrictions may apply. In 2011, 96.8% of CIMZIA Co-Pay Savings Card users paid no out-of-pocket costs.

*Not valid for prescriptions that are reimbursed, in whole or part, under Medicare (including Medicare Part D), Medicaid, similar federal- or state-funded programs (including any state prescription drug assistance programs and the Government Health Insurance Plan available in Puerto Rico) or where otherwise prohibited by law. Product dispensed pursuant to program rules and federal and state laws. Claims should not be submitted to any public payor (i.e., Medicare, Medicaid, Medigap, Tricare, VA and DoD) for reimbursement. Patients and pharmacists are responsible for notifying insurance carriers or other third party who pays for or reimburses any part of the prescription filled using this card as may be required by the insurance carrier’s terms and conditions and applicable law. The parties reserve the right to amend or end this program at any time without notice.

Important Safety Information

You are encouraged to report side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Important Safety Information Regarding Fungal Infections
Unsubscribe